Clarithromycin (Klacid XL) Dosing for 45 kg Pediatric Patient with Pneumonia
For a 45 kg child with pneumonia, use clarithromycin 15 mg/kg/day divided into 2 doses (approximately 337.5 mg twice daily, which can be rounded to 375 mg twice daily using available formulations) for 5-7 days. 1
Important Clarification
The question asks about "Klacid XL" but the provided FDA drug label 2 appears to be for an unrelated product (likely acetaminophen based on the dosing and warnings). Klacid is the brand name for clarithromycin, a macrolide antibiotic appropriate for pneumonia treatment.
Dosing Algorithm
For Atypical Pneumonia Coverage (Mycoplasma, Chlamydophila)
Clarithromycin is the preferred oral macrolide:
- Dose: 15 mg/kg/day divided into 2 doses
- For 45 kg patient: 337.5 mg twice daily (round to 375 mg BID using available tablets)
- Duration: 5-7 days
- Maximum daily dose: Do not exceed adult dose (1000 mg/day total) 1
Alternative: Azithromycin (if preferred)
- Day 1: 10 mg/kg once daily (450 mg)
- Days 2-5: 5 mg/kg once daily (225 mg)
- Total 5-day course 1
Clinical Context
The 2011 PIDS/IDSA guidelines 1 provide the most authoritative recommendations for pediatric community-acquired pneumonia. These guidelines specify that:
- Macrolides should be added to β-lactam therapy when atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae) are suspected, particularly in children over 5 years old
- For hospitalized children requiring combination therapy, macrolides are given alongside β-lactam antibiotics
- For outpatient management where atypical pathogens are the primary concern, macrolide monotherapy may be appropriate
Key Considerations
When to Use Clarithromycin:
- School-age children (>5 years) with pneumonia where atypical organisms are likely
- Patients with β-lactam allergy requiring alternative coverage
- As part of combination therapy for hospitalized patients
Pitfalls to Avoid:
- Do not use macrolide monotherapy for typical bacterial pneumonia in young children where Streptococcus pneumoniae is the primary concern—amoxicillin remains first-line 1
- Avoid prolonged courses beyond 7 days unless treating specific resistant organisms
- Check for drug interactions, particularly with medications metabolized by CYP3A4
- Monitor for QT prolongation in patients with cardiac risk factors
Treatment Duration:
- Standard course: 5-7 days is adequate for most cases 1
- The guidelines emphasize that 10-day courses have been best studied, but shorter courses (5 days) are equally effective for mild-to-moderate disease 1
- Certain pathogens like CA-MRSA may require longer treatment, but this is not relevant for typical macrolide-responsive organisms 1
Dosing Summary for 45 kg Patient
Clarithromycin: 375 mg PO twice daily × 5-7 days
OR
Azithromycin: 450 mg PO once on Day 1, then 225 mg PO once daily Days 2-5
Both regimens provide appropriate coverage for atypical pneumonia pathogens with excellent safety profiles in this age group.